Mamucan, Shaina T.
HRN: 24-19-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2023
CEFTRIAXONE 1G (VIAL)
12/09/2023
12/16/2023
IV
1g
OD
PCAP-severe; T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes